ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
Aβ1-40 induces venular endothelial cell ferroptosis in cerebral amyloid angiopathy via the ATF3/xCT axis: Insights from single-cell RNA sequencing.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionAmyloid-beta (Aβ)-induced microvascular injury is a key pathological feature of cerebral amyloid angiopathy (CAA). Recent evidence suggests that ferroptosis is implicated in Aβ pathology; however, its cell-type specificity and regulatory mechanisms within the cerebral microvasculature in CAA remain unclear.
methodsSingle-cell RNA sequencing (scRNA-seq) was performed on cortical microvessels from 11-month-old APP23 mice and wild-type littermates to identify cell-type-specific ferroptosis signatures. Biochemical, histopathological, and intervention experiments were further conducted to validate the findings and investigate the underlying mechanisms.
resultsVenous endothelial cluster exhibited the most prominent enrichment of ferroptosis signatures in scRNA-seq analysis, with subsequent experiments demonstrating progressive ferroptosis-related alterations in cortical venular endothelial cells (vECs) during CAA development. Mechanistically, Aβ1-40 increased activating transcription factor 3 (ATF3) expression and its occupancy at the Slc7a11 promoter, whereas ATF3 silencing restored Slc7a11/xCT expression, supporting ATF3-mediated Slc7a11/xCT repression and consequent impairment of glutathione-dependent antioxidant defense. Importantly, endothelial ATF3 knockdown attenuated ferroptosis-related alterations in vECs, reduced cerebral Aβ burden, and ameliorated cognitive deficits in APP23 mice. DISCUSSION: This study uncovers a previously underrecognized Aβ-driven microvascular injury characterized by vEC ferroptosis and highlights the ATF3/xCT axis as a potential therapeutic target in the early stage of CAA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.